Evidence map›Paper›PMID 38254639›Full record

ReviewBiomolecules2023

The Role of the Complement System in the Pathogenesis of Infectious Forms of Hemolytic Uremic Syndrome.

Piotr P Avdonin, Maria S Blinova, Galina A Generalova, Khadizha M Emirova, Pavel V Avdonin

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Biomolecules, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Immunity and Coagulation in COVID-19.International journal of molecular sciences · 2024
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Piotr P AvdoninKoltzov Institute of Developmental Biology RAS, ul. Vavilova, 26, 119334 Moscow, Russia.
Maria S BlinovaKoltzov Institute of Developmental Biology RAS, ul. Vavilova, 26, 119334 Moscow, Russia.
Galina A GeneralovaSaint Vladimir Moscow City Children's Clinical Hospital, 107014 Moscow, Russia.
Khadizha M EmirovaSaint Vladimir Moscow City Children's Clinical Hospital, 107014 Moscow, Russia.
Pavel V AvdoninKoltzov Institute of Developmental Biology RAS, ul. Vavilova, 26, 119334 Moscow, Russia.ORCID 0000-0002-4138-1589
Koltzov Institute of Developmental Biology · RUMoscow State University of Medicine and Dentistry · RU

Funding

Russian Science Foundation grant 22-15-00409
6 · The paper itself

Abstract

Hemolytic uremic syndrome (HUS) is an acute disease and the most common cause of childhood acute renal failure. HUS is characterized by a triad of symptoms: microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury. In most of the cases, HUS occurs as a result of infection caused by Shiga toxin-producing microbes: hemorrhagic

Indexed as

Acute Kidney InjuryAtypical Hemolytic Uremic SyndromeVirus DiseasesComplement System ProteinsEscherichia coliHumansComplement System Proteinsacute renal failurecomplement systemeculizumabendotheliumEscherichia colihemolytic anemiahemolytic uremic syndromepathogenesisShiga toxinSTEC-HUSthrombocytopeniathrombotic microangiopathy

Identifiers

PMID38254639
PMCPMC10813406
OpenAlexW4390272453

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.